This study published in Thorax explores the role of blood fibrinogen as a biomarker in chronic obstructive pulmonary disease (COPD). The review suggests that fibrinogen levels are significantly associated with COPD presence, exacerbation frequency, and mortality risk, making it a potential biomarker for risk stratification. However, fibrinogen does not predict
